Table: Green Peptide -9-MTH group results

BrightPath Biotherapeutics Co

10/02/2017 07:45

Feb 10 (Reuters)-  
             Green Peptide Co., Ltd.  
             CONSOLIDATED FINANCIAL HIGHLIGHTS  
     (in billions of yen unless specified)                 
                 9 months ended      9 months ended        Year to   
                Dec 31, 2016        Dec 31, 2015      Mar 31, 2017   
                   LATEST             YEAR-AGO           LATEST      
                   RESULTS             RESULTS          FORECAST     
  Sales            431 mln                               406 mln     
  Operating     loss 699 mln                            loss 1.31    
  Recurring     loss 711 mln                            loss 1.31    
  Net           loss 712 mln                            loss 1.31    
  EPS          loss 21.45 yen                        loss 41.14 yen  
  Ann Div                                NIL               NIL       
  -Q2 div            NIL                 NIL                         
  -Q4 div                                NIL               NIL       
   
  NOTE - Green Peptide Co., Ltd..  
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4594.T 
  ((Tokyo Headline News Desk +813 6441 1812))